AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2023
Nov 21, 2023
29821_dirs_2023-11-21_69db0876-cceb-4343-9bca-7e695724d8e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2023-11-20
Reporting Person: Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-20 | Common Stock | M | 3859.0000 | $17.2600 | Acquired | 15255.0000 | Direct |
| 2023-11-20 | Common Stock | S | 8278.0000 | $54.0600 | Disposed | 6977.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-11-20 | Stock Option (Right to Buy) | $17.2600 | M | 3859.0000 | Disposed | 2026-02-22 | Common Stock (3859.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2545.0000 | Indirect |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2023, intended to comply with the prior version of Rule 10b5-1(c).
F2: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.